Fallopian tube carcinoma: A clinicopathological study of 17 cases

King, Alan; Seraj, Ibrahim M.; Thrasher, Thais V.; Slater, James M.; Wagner, Robert J.

doi:10.1016/0090-8258(89)90526-x

Cited by 35 publications

(25 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…There are very few data that are extractable from the literature with regard to PFTC. Several authors using cisplatin-based chemotherapy in patients with advanced PFTC reported overall responses rates of 53%-92% [4,49,50,68,70,92,94,96,99]. Peters et al [50] reported a 75% complete response rate in a study of 46 patients with advanced or recurrent PFTC.…”

Section: Combination Chemotherapy For Advanced Diseasementioning

confidence: 99%

“…Radiotherapy could possibly be considered either as adjuvant therapy for early-stage patients [2,5,28,45,46,73,85,[93][94][95][96], for stage III residual negative patients, or in the relapse setting. Although radiotherapy has been used traditionally in the past as an adjuvant therapy for PFTC, its role in the era of effective chemotherapy is less well defined and controversial.…”

Section: Radiotherapymentioning

confidence: 99%

See 1 more Smart Citation

Fallopian Tube Carcinoma: A Review

2006

View full text Add to dashboard Cite

Purpose. Primary fallopian tube carcinoma (PFTC) is a rare tumor that histologically and clinically resembles epithelial ovarian cancer (EOC). The purpose of this study is to review the current available literature data on PFTC.Patients and Results. Early clinical manifestation and prompt investigation often lead to diagnosis at an early stage of disease. However, the diagnosis of PFTC is rarely considered preoperatively and is usually first appreciated by the pathologist. Surgical staging/management and the use of chemotherapy follow the concepts used in epithelial ovarian cancer (EOC). In contrast to EOC is the importance of early lymphatic spread in this disease. The earlier diagnosis of PFTC leads to an apparent better survival compared with EOC. However, as with EOC, stage and residual tumor are the most important prognostic variables.Conclusion. Until more extensive clinical research has been performed, ovarian carcinoma management principles should be used in clinical practice. The Oncologist 2006;11:902-912

show abstract

Section: Combination Chemotherapy For Advanced Diseasementioning

confidence: 99%

Section: Radiotherapymentioning

confidence: 99%

Fallopian Tube Carcinoma: A Review

2006

View full text Add to dashboard Cite

show abstract

“…Symptoms are usually absent in the early stages of the disease, although as the malignancy grows, it may present with a watery vaginal discharge, abnormal uterine bleeding and pelvic pain. 5,6,9 Dissemination of the disease occurs to the ovaries, pelvic structures, lymph nodes and other organs. 3,10,17 Histologically, the majority of malignant fallopian tube tumors are adenocarcinomas of the serous type, morphologically indistinguishable from serous malignancies of the ovaries.…”

Section: Discussionmentioning

confidence: 99%

Psammoma Bodies and Cells from <i>in Situ</i> Fallopian Tube Carcinoma in Endometrial Smears

Luzzatto¹,

Sisson²,

Luzzatto³

et al. 1996

Acta Cytologica

View full text Add to dashboard Cite

“…Carcinoma of the Fallopian tube accounts for less than 2% of all gynaecological malignancies (Picha and Weghaupt 1970, Pohl 1984, Asmussen 1988, King 1989. It is an aggressive tumour with a poor prognosis.…”

Section: Discussionmentioning

confidence: 98%